Author

Richard C. Yu

ORCID 0000-0002-4517-3082Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Lauren J. SchwimmeriD· 2 shared Swastik Sen· 2 shared Andrea G. HohmanniD· 1 shared Carlos Henrique Alves JesusiD· 1 shared Dipankar BhattacharyaiD· 1 shared Emily Fender SizemoreiD· 1 shared Gopireddy Raghavender ReddyiD· 1 shared Jonah L. WirtiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Lauren J. SchwimmerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyMolecular PharmacologyPeer-reviewedJan 14, 2026

Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases

Raghavender Reddy Gopireddy, Dipankar Bhattacharya, Swastik Sen…·Lauren J. Schwimmer

This paper introduces two novel CB2-specific agonist antibodies that reduce macrophage activation and fibrosis in vitro and an ex vivo liver model.

3 citationstop 4%

humanexperimental assay

NeurosciencebioRxivPreprintNov 26, 2025

CB2 cannabinoid receptor-specific therapeutic antibody agonists for treatment of chemotherapy-induced peripheral neuropathy

Carlos Henrique Alves Jesus, Gopireddy Raghavender Reddy, Emily Fender Sizemore…·Andrea G. Hohmann

This study evaluates CB2-specific antibody agonists for treating chemotherapy-induced peripheral neuropathy, showing pain relief without tolerance or off-target effects.

DOI 10.1101/2025.11.26.690750

mouseexperimental assay